Literature DB >> 30298845

Principles of precision medicine and its application in toxicology.

Jon C Cook1, Hong Wu1, Michael D Aleo1, Karissa Adkins1.   

Abstract

Precision medicine is an approach to developing drugs that focuses on employing biomarkers to stratify patients in clinical trials with the goal of improving efficacy and/or safety outcomes, ultimately increasing the odds of clinical success and drug approval. Precision medicine is an important tool for toxicologists to utilize, because its principles can be used to decide whether to pursue a drug target, to understand interindividual differences in response to drugs in both nonclinical and clinical settings, to aid in selecting doses that optimize efficacy or reduce adverse events, and to facilitate understanding of a drug's mode-of-action. Nonclinical models such as the mouse and non-human primate can be used to understand genetic variation and its potential translation to humans, and are available for toxicologists to employ in advance of drugs moving into clinical development. Understanding interindividual differences in response to drugs and how these differences can influence the drug's risk-benefit profile and lead to the identification of biomarkers that enhance patient efficacy and safety is of critical importance for toxicologists today, and in the future, as the fields of pharmacogenomics and genetics continue to advance.

Entities:  

Keywords:  Interindividual variability; Pharmacogenomics; Precision medicine; Review; Safety assessment

Mesh:

Year:  2018        PMID: 30298845     DOI: 10.2131/jts.43.565

Source DB:  PubMed          Journal:  J Toxicol Sci        ISSN: 0388-1350            Impact factor:   2.196


  9 in total

1.  Comparing Machine Learning Algorithms for Predicting Drug-Induced Liver Injury (DILI).

Authors:  Eni Minerali; Daniel H Foil; Kimberley M Zorn; Thomas R Lane; Sean Ekins
Journal:  Mol Pharm       Date:  2020-06-08       Impact factor: 4.939

Review 2.  Using human genetics to improve safety assessment of therapeutics.

Authors:  Keren J Carss; Aimee M Deaton; Alberto Del Rio-Espinola; Dorothée Diogo; Mark Fielden; Diptee A Kulkarni; Jonathan Moggs; Peter Newham; Matthew R Nelson; Frank D Sistare; Lucas D Ward; Jing Yuan
Journal:  Nat Rev Drug Discov       Date:  2022-10-19       Impact factor: 112.288

Review 3.  A decade of toxicological trends: what the papers say.

Authors:  Phumzile Sikakana; Ruth A Roberts
Journal:  Toxicol Res (Camb)       Date:  2020-10-08       Impact factor: 3.524

4.  Use of Titration as a Therapeutic Individualization Strategy: An Analysis of Food and Drug Administration-Approved Drugs.

Authors:  Robert N Schuck; Michael Pacanowski; Sarah Kim; Rajanikanth Madabushi; Issam Zineh
Journal:  Clin Transl Sci       Date:  2019-03-12       Impact factor: 4.689

5.  Clinical protein science in translational medicine targeting malignant melanoma.

Authors:  Jeovanis Gil; Lazaro Hiram Betancourt; Indira Pla; Aniel Sanchez; Roger Appelqvist; Tasso Miliotis; Magdalena Kuras; Henriette Oskolas; Yonghyo Kim; Zsolt Horvath; Jonatan Eriksson; Ethan Berge; Elisabeth Burestedt; Göran Jönsson; Bo Baldetorp; Christian Ingvar; Håkan Olsson; Lotta Lundgren; Peter Horvatovich; Jimmy Rodriguez Murillo; Yutaka Sugihara; Charlotte Welinder; Elisabet Wieslander; Boram Lee; Henrik Lindberg; Krzysztof Pawłowski; Ho Jeong Kwon; Viktoria Doma; Jozsef Timar; Sarolta Karpati; A Marcell Szasz; István Balázs Németh; Toshihide Nishimura; Garry Corthals; Melinda Rezeli; Beatrice Knudsen; Johan Malm; György Marko-Varga
Journal:  Cell Biol Toxicol       Date:  2019-03-21       Impact factor: 6.691

6.  Phase I study of PF‐04895162, a Kv7 channel opener, reveals unexpected hepatotoxicity in healthy subjects, but not rats or monkeys: clinical evidence of disrupted bile acid homeostasis.

Authors:  Michael D Aleo; Jiri Aubrecht; Paul D Bonin; Deborah A Burt; Jennifer Colangelo; Lina Luo; Shelli Schomaker; Rachel Swiss; Simon Kirby; Greg C Rigdon; Pinky Dua
Journal:  Pharmacol Res Perspect       Date:  2019-02

7.  Influenza infection elicits an expansion of gut population of endogenous Bifidobacterium animalis which protects mice against infection.

Authors:  Qiang Zhang; Jin Hu; Jia-Wu Feng; Xiao-Tong Hu; Ting Wang; Wen-Xiao Gong; Kun Huang; Yi-Xiong Guo; Zhong Zou; Xian Lin; Run Zhou; Yu-Qi Yuan; An-Ding Zhang; Hong Wei; Gang Cao; Chen Liu; Ling-Ling Chen; Mei-Lin Jin
Journal:  Genome Biol       Date:  2020-04-28       Impact factor: 13.583

8.  Akkermansia muciniphila Improves Host Defense Against Influenza Virus Infection.

Authors:  Xiaotong Hu; Ya Zhao; Yong Yang; Wenxiao Gong; Xiaomei Sun; Li Yang; Qiang Zhang; Meilin Jin
Journal:  Front Microbiol       Date:  2021-02-02       Impact factor: 5.640

9.  Phenobarbital use in benzodiazepine and z-drug detoxification: a single-centre 15-year observational retrospective study in clinical practice.

Authors:  Simone Sartori; Giada Crescioli; Guido Mannaioni; Niccolò Lombardi; Valentina Brilli; Sara Traversoni; Cecilia Lanzi; Alfredo Vannacci
Journal:  Intern Emerg Med       Date:  2022-04-12       Impact factor: 5.472

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.